InvestorsHub Logo
Followers 1
Posts 17
Boards Moderated 0
Alias Born 10/27/2014

Re: None

Friday, 06/19/2015 10:34:31 AM

Friday, June 19, 2015 10:34:31 AM

Post# of 6725
Contrary to the clear 4/22 PR with the info about the 100% survival rate (Makona preclinical efficacy results in monkeys), this last PR was not transparent & charged with failure innuendo.

No one asked for a PR to inform us when the statistical endpoint enrollment was closed...How does this help investors?

The price collapse with high volume (1st hour higher vol that all of Wednesday) shows that most investors dislike this insecurity/BS.

Who approved this PR? Why?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News